Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Here, we present a fibrinogen-polyacrylamide gel electrophoresis (PAGE) protocol to rapidly separate and display the fibrinogenolytic agents of Sipunculus nudus.

Abstract

Fibrinogenolytic agents that can dissolve fibrinogen directly have been widely used in anti-coagulation treatment. Generally, identifying new fibrinogenolytic agents requires the separation of each component first and then checking their fibrinogenolytic activities. Currently, polyacrylamide gel electrophoresis (PAGE) and chromatography are mostly used in the separating stage. Meanwhile, the fibrinogen plate assay and reaction products based PAGE are usually adopted to display their fibrinogenolytic activities. However, because of the spatiotemporal separation of those two stages, it is impossible to separate and display the active fibrinogenolytic agents with the same gel. To simplify the separating and displaying processes of fibrinogenolytic agent identification, we constructed a new fibrinogen-PAGE method to rapidly separate and display the fibrinogenolytic agents of peanut worms (Sipunculus nudus) in this study. This method includes fibrinogen-PAGE preparation, electrophoresis, renaturation, incubation, staining, and decolorization. The fibrinogenolytic activity and molecular weight of the protein can be detected simultaneously. According to this method, we successfully detected more than one active fibrinogenolytic agent of peanut wormhomogenate within 6 h. Moreover, this fibrinogen-PAGE method is time and cost-friendly. Furthermore, this method could be used to study the fibrinogenolytic agents of the other organisms.

Introduction

In recent years, due to the continued rise of thrombotic diseases, thrombotic diseases have become a new major global health problem1. At present, antithrombotic drugs are classified into three groups: anti-platelet aggregation drugs, anticoagulants, and thrombolytic drugs. Among them, thrombolytic drugs, such as urokinase (UK), tissue plasminogen activator (tPA), etc., are the only clinically used drugs that can hydrolyze thrombus2. Meanwhile, more safe and effective thrombolytic drugs are being developed by the identification of novel thrombolytic agents3.

However, th....

Protocol

1. Peanut worm homogenate preparation

  1. Add 50 g of peanut worms and 150 mL of saline solution into the homogenizer.
  2. Homogenize at 24000 rpm for 60 s.
    NOTE: Repeat 3 times.
  3. Centrifuge the homogenate at 9710 x g for 30 min at 4 °C.
  4. Collect the supernatant as the peanut worm homogenate for further study.

2. Fibrinogen-PAGE gel preparation

  1. Weigh 0.01 g of fibrinogen into a 50 mL glass.......

Representative Results

After electrophoresis, all the bands of the marker were clearly displayed. The 1x SDS-PAGE loading lanes only showed 10 kDa bands (bromophenol blue). The sFE and peanut worm samples did not show any observable bands (Figure 1). Although the bands of the samples are not visible, the performance of the marker and bromophenol blue indicated that the electrophoresis was successful, and the samples were separated according to their molecular weight.

Although the whole .......

Discussion

sFE is a novel fibrino(geno)lytic enzyme isolated from peanut worms by our team previously3,6,8,13. However, the identification processes of sFE were time- and labor-consuming, involving the fibrinogenolytic activity detection, protein components separation, and activity confirmation stages. As a simple method, fibrinogen plate assay is mostly used in the preliminary screening stage to check th.......

Acknowledgements

This research was funded by the Science and Technology Bureau of Xiamen City (No. 3502Z20227197), the Science and Technology Bureau of Fujian Province (No. 2019J01070; No. 2022J01311), and High-level Talents Innovation and Entrepreneurship Project of Quanzhou Science and Technology Plan (No. 2022C015R). We thank Fucai Wang (Huaqiao University) and Lei Tong (Huaqiao University) for their technical assistance.

....

Materials

NameCompanyCatalog NumberComments
1  M Tris-HCl (pH 6.8)SolarbioT1020
1.5 M Tris-HCl (pH 8.8)SolarbioT1010
30% Acrylamide/Bis-acrylamideBiosharpBL513B
Ammonium persulfateXiLONG SCIENTIFIC7727-54-0
BeakerPYREX2-9425-02
Centrifuge Tube (1.5 mL)BiosharpBS-15-M
Constant Temperature IncubatorJINGHONGJHS-400
Coomas Brillant Blue Stainning solutionBeyotimeP0017F
Electronic Analytical BalanceDENVERTP-213
FibrinogenSolarbioF8051
Gel loading pipette tips, BulkBiosharpBS-200-GTB
HomogenizerAHSATS-1500
Horizontal rotation oscillatorNuoMiNMSP-600
Milli-Q ReferenceMilliporeZ00QSV0CN
Mini-PROTEAN Tetra CellBIO-RAD165-8000~165-8007
N,N,N',N'-TetramethylethylenediamineSigmaT9281
Pipette Tip (1 mL)AxygeneT-1000XT-C
Pipette Tip (10 µL)AxygeneT-10XT-C
Pipette Tip (200 µL)AxygeneT-200XT-C
Pipettor (1 mL)Thermo Fisher ScientificZY18723
Pipettor (10µL)Thermo Fisher ScientificZX98775
Pipettor (200 µL)Thermo Fisher ScientificZY20280
Pipettor (50 µL)Thermo Fisher ScientificZY15331
Refrigerated CentrifugecenceH1650R
Sodium dodecyl sulfateSigma-AldrichV900859
TrisSolarbioT8060
Tris-HClSolarbioT8230
Triton X-100SolarbioT8200

References

  1. Bikdeli, B., et al. COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 75 (23), 2950-2973 (2020).
  2. Tsivgoulis, G., et al.

Explore More Articles

Fibrinogenolytic AgentsFibrinogen polyacrylamide Gel Electrophoresis fibrinogen PAGESipunculus NudusRapid SeparationActive Fibrinogenolytic AgentsAnti coagulation TreatmentFibrinogenolytic ActivityMolecular Weight

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved